Skip to megamenu (after main content)
Meet us next:   ELRIG UK 2025 – 20 March  ●  IBD Innovate 2025 – 9-10 April  ●  NIH Spring Vendor Exhibit 2025 – 24 April  ●  AACR Annual Meeting 2025 – 27-30 April  ●  ISCT Conference 2025 – 7-9 May  ●  more on our events calendar

Recombinant human SCF protein

QK078

Brand: Qkine

Stem Cell Factor (SCF) is a critical factor in the maintenance and expansion of hematopoietic stem cells (HSCs) in the bone marrow microenvironment. Key myeloid progenitor differentiation factor for a variety of myeloid cells such as megakaryocytes, basophils, neutrophils, and monocytes, Stem Cell Factor is also a primary growth and activation factor for mast cells and eosinophils.

Recombinant SCF is a highly pure 18.5 kDa monomer, animal origin-free (AOF) and carrier-protein-free (CF). Qkine has optimised the SCF manufacture process to produce a highly bioactive protein with excellent lot-to-lot consistency for enhanced experimental reproducibility.

Qkine 3-for-2 product campaign

Currency: 

Product name Catalog number Pack size Price Price (USD) Price (GBP) Price (EUR)
Recombinant human SCF protein, 25 µg QK078-0025 25 µg (select above) $ 210.00 £ 155.00 € 182.00
Recombinant human SCF protein, 50 µg QK078-0050 50 µg (select above) $ 315.00 £ 225.00 € 263.00
Recombinant human SCF protein, 100 µg QK078-0100 100 µg (select above) $ 500.00 £ 375.00 € 438.00
Recombinant human SCF protein, 500 µg QK078-0500 500 µg (select above) $ 1,995.00 £ 1,475.00 € 1,723.00
Recombinant human SCF protein, 1000 µg QK078-1000 1000 µg (select above) $ 3,100.00 £ 2,300.00 € 2,687.00

Note: prices shown do not include shipping and handling charges.

Qkine company name and logo are the property of Qkine Ltd. UK.

Alternative protein names
Mast cell growth factor (MGF)
Stem cell growth factor(SCF)
C-kit ligand
Species reactivity

human

species similarity:
mouse – 79%
rat – 79%
porcine – 83%
bovine – 82%


Summary

  • High purity human protein (Uniprot number: P21583)
  • >98%, by SDS-PAGE quantitative densitometry
  • Source: Expressed in E. coli
  • 18.5 kDa (monomer)
  • Animal origin-free (AOF) and carrier protein-free
  • Manufactured in Cambridge, UK
  • Lyophilized from Acetonitrile/TFA
  • Resuspend in water at >100 µg/mL, prepare single-use aliquots, add carrier protein if desired, and store frozen at -20°C or -80°C.
Handling and Storage FAQ

Featured applications

  • Maintenance and expansion of hematopoietic stem cells, neural stem cells, and mesenchymal stem cells
  • Cancer research, including the SCF/c-kit pathway
  • Hematopoietic differentiation to multiple myeloid blood lineages
  • Tissue morphogenesis during embryonic development
  • Proliferation and migration of cardiac progenitor cells
  • Development and maintenance of mast cells, dendritic cells, and T cells

Bioactivity

Recombinant SCF activity is determined using proliferation of TF-1 human myeloid leukemia cells. Cells are treated in triplicate with a serial dilution of SCF for 48 hours. Cell viability is measured using the CellTiter-Glo (Promega) luminescence assay. Data from Qk078 lot #204621. EC50 = 1.41 ng/mL (76 pM).

Purity

Qk078 SCF gel

Recombinant SCF migrates at approximately 18 kDa (monomer) in reduced (R) and at approximately 15 kD in non-reduced (NR) conditions. No contaminating protein bands are present. The purified recombinant protein (3 µg) was resolved using 15% w/v SDS-PAGE in reduced (+β-mercaptoethanol, R) and non-reduced (NR) conditions and stained with Coomassie Brilliant Blue R250. Data from Qk078 lot #204621.

Further quality assays

  • Mass spectrometry, single species with the expected mass
  • Endotoxin: <0.005 EU/μg protein (below the level of detection)
  • Recovery from stock vial: >95%

Qkine SCF has equivalent bioactivity to SCF from an alternative major supplier

Recombinant SCF activity was determined using proliferation of TF-1 human myeloid leukemia cells. Cells were treated in triplicate with a serial dilution of SCF for 48 hours. Cell viability was measured using the Cell Titer-Glo (Promega) luminescence assay. Data from Qk078 lot #204613. EC50 = Qk078: 2.86 ng/mL (154 pM). Supplier B: 3.05 ng/ml (166 pM)


Protein background

Stem Cell Factor (SCF), also known as kit-ligand or mast cell growth factor, is a pivotal protein in stem cell function, from embryonic development to tissue regeneration and cancer biology [1]. SCF functions primarily through interaction with its receptor, c-kit, a transmembrane tyrosine kinase receptor expressed on the surface of various cell types, including hematopoietic stem cells, neural crest-derived cells, melanocytes, and germ cells. Upon binding to c-kit, it triggers a cascade of intracellular signaling pathways, such as the Ras/MAPK, PI3K/Akt, and JAK/STAT pathways, which regulate cell proliferation, survival, migration, and differentiation [2,3].

Stem Cell Factor serves as a crucial ligand for its receptor, c-Kit, initiating signaling cascades upon binding. SCF can also be processed into a soluble form through proteolytic cleavage near the cell membrane. This cleavage releases the extracellular domain of SCF into the extracellular space, generating soluble SCF. Despite this modification, soluble SCF retains its ability to bind to c-Kit and activate downstream signaling pathways. Soluble SCF may act as a paracrine or autocrine factor, exerting its effects on nearby cells or the same cell producing it [3,4].

One of the key roles of SCF is in hematopoiesis, where SCF acts as a critical factor in the maintenance and expansion of hematopoietic stem cells (HSCs) in the bone marrow microenvironment [5,6]. It not only promotes the self-renewal of HSCs but also facilitates their differentiation into various blood cell lineages, including red blood cells, mast cells, and platelets [4].

Stem Cell Factor plays a crucial role in embryonic development, where it contributes to the formation of various tissues and organs. During embryogenesis, SCF is implicated in the proliferation, migration, and survival of neural crest cells, which give rise to a diverse array of cell types, including neurons, glial cells, melanocytes, and smooth muscle cells [7].

Beyond its roles in normal physiology, dysregulation of SCF signaling is associated with various pathological conditions, including cancer [8]. Aberrant activation of the SCF/c-kit pathway is observed in certain types of cancer, such as gastrointestinal stromal tumors (GISTs), acute myeloid leukemia (AML), and melanoma. In these malignancies, mutations in c-kit or overexpression of SCF contribute to uncontrolled cell proliferation, survival, and metastasis, making the SCF/c-kit axis an attractive target for cancer therapy [9].

Background references

    1. Huang EJ, Nocka KH, Buck J, Besmer P. Differential expression and processing of two cell associated forms of the kit-ligand: KL-1 and KL-2. Mol Biol Cell. 1992;3(3):349-362. https://doi.org/10.1091/mbc.3.3.349
    2. Lennartsson J, Rönnstrand L. Stem cell factor receptor/c-Kit: from basic science to clinical implications. Physiol Rev. 2012;92(4):1619-1649. https://doi.org/10.1152/physrev.00046.2011
    3. Yuzawa S, Opatowsky Y, Zhang Z, Mandiyan V, Lax I, Schlessinger J. Structural basis for activation of the receptor tyrosine kinase KIT by stem cell factor. Cell. 2007;130(2):323-334. doi: 10.1016/j.cell.2007.05.055
    4. Huang EJ, Nocka KH, Buck J, Besmer P. Differential expression and processing of two cell associated forms of the kit-ligand: KL-1 and KL-2. Mol Biol Cell. 1992;3(3):349-362. doi:10.1091/mbc.3.3.349
    5. Blume-Jensen P, Janknecht R, Hunter T. The kit receptor promotes cell survival via activation of PI 3-kinase and subsequent Akt-mediated phosphorylation of Bad on Ser136. Curr Biol. 1998;8(13):779-782. https://doi.org/10.1016/s0960-9822(98)70300-2
    6. Zsebo KM, Williams DA, Geissler EN, et al. Stem cell factor is encoded at the Sl locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell. 1990;63(1):213-224. https://doi.org/10.1016/0092-8674(90)90303-v
    7. Waskow C, Madan V, Bartels S, et al. Hematopoietic stem cell transplantation without irradiation. Nat Methods. 2009;6(4):267-269. https://doi.org/10.1038/nmeth.1314
    8. Hu Y, Smyth GK. ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J Immunol Methods. 2009;347(1-2):70-78. https://doi.org/10.1016/j.jim.2009.06.008
    9. Linnekin D. Early signaling pathways activated by c-Kit in hematopoietic cells. Int J Biochem Cell Biol. 1999;31(10):1053-1074. https://doi.org/10.1016/s1357-2725(99)00076-0

Publications using recombinant human SCF protein (Qk078)

STAT3 signalling enhances tissue expansion during postimplantation mouse development
bioRxiv preprint (2024) by Azami, T. et al.
View publication